Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results

被引:1
|
作者
Garcia-Moll, Xavier [1 ]
Lopez, Laura [1 ]
机构
[1] Hosp Holy Cross & St Paul, Cardiol Dept, Barcelona, Spain
关键词
HEART-FAILURE;
D O I
10.1016/j.ijcard.2023.131706
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Olaparib treatment in older patients with ovarian cancer: need for 'real-world' data beyond clinical trials
    Liposits, Gabor
    Wulff, Christian Nielsen
    Otland, Anne
    Fokdal, Lars Ulrik
    ECANCERMEDICALSCIENCE, 2020, 14
  • [22] BRIDGING THE GAP BETWEEN CLINICAL TRIALS AND REAL WORLD DATA: EVIDENCE ON REPLICABILITY OF EFFICACY RESULTS USING GERMAN CLAIMS DATA
    Ghiani, M.
    Maywald, U.
    Wilke, T.
    Heeg, B.
    VALUE IN HEALTH, 2020, 23 : S757 - S758
  • [23] Pharmacovigilance study for SGLT 2 inhibitors- Safety review of real-world data & randomized clinical trials
    Bhanushali, Karan B.
    Asnani, Heena K.
    Nair, Ambica
    Ganatra, Sarju
    Dani, Sourbha S.
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (09)
  • [24] Post-Marketing Safety Surveillance of Vaccines in Japan for Older Adults: A Feasibility Assessment of Real-World Data Capabilities
    Zhou, Cindy Ke
    Yasui, Daisaku
    Yoshinaga, Eiko
    Pearce, Kristina
    Martin, David
    Esposito, Daina B.
    Kubo, Tadamichi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 274 - 275
  • [25] Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia
    Hsieh, Stephanie
    Yuan, Jing
    Lu, Z. Kevin
    Li, Minghui
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [26] Clinical Characteristics and Dosing Patterns of Tirzepatide among Adults without Type 2 Diabetes-Real-World Results
    Gibble, Theresa Hunter
    Chinthammit, Chanadda
    Ward, Jennifer
    Cappell, Katherine
    Sedgley, Robert
    Bonafede, Mac
    Liao, Birong
    Hankosky, Emily R.
    DIABETES, 2024, 73
  • [27] The real-world safety profile of SGLT2 inhibitors among adults 75 years or older: a retrospective, pharmacovigilance study
    Goldman, A.
    Fishman, B.
    Raschi, E.
    Cukierman-Yaffe, T.
    Dankner, R.
    Ben-Zvi, I.
    Maor, E.
    EUROPEAN HEART JOURNAL, 2022, 43 : 973 - 973
  • [28] Prediction of treatment nonadherence among older adults with chronic obstructive pulmonary disease using Medicare real-world data
    Le, Tham T.
    Bjarnadottir, Margret
    Qato, Danya M.
    Magder, Larry
    Zafari, Zafar
    Simoni-Wastila, Linda
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (06): : 631 - 644
  • [29] Bridging the gap between oncology clinical trials and real-world data: evidence on replicability of efficacy results using German claims data
    Ghiani, Marco
    Maywald, Ulf
    Wilke, Thomas
    Heeg, Bart
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (07) : 513 - 521
  • [30] Clinical results of randomized trials and "real-world' data exploring the impact of Bevacizumab for breast cancer: opportunities for clinical practice and perspectives for research
    Zambonin, Valentina
    De Toma, Alessandro
    Carbognin, Luisa
    Nortilli, Rolando
    Fiorio, Elena
    Parolin, Veronica
    Pilotto, Sara
    Cuppone, Federica
    Pellini, Francesca
    Lombardi, Davide
    Pollini, Giovanni Paolo
    Tortora, Giampaolo
    Bria, Emilio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (04) : 497 - 506